MEDICINAL
ActiveMEDICINAL has been active since 2014 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.67M and a net result of €141k. Equity is growing by ~15.9% per year across the filed fiscal years. Its solvency ranks better than 74% of 8592 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
64
/ 100
Healthy▲ +8 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability42▼-3
Solvency67=
Growth52=
Stability100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €110k at 30 days acceptable
Liquidity short (current ratio 0.15 against 0.27 in 2024), and 21.8% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 70
Relative position
BE, all sectors
reference
Sector 70
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
78.2%
Return on assets
6.6%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-08-2026, 13 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
13 d late
2024
20 d late
2023
20 d late
2022
22 d late
2021
13 d early
2020
12 d late
2019
4 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
16-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€1.67M▲ 9.2%
2024 · €1.53M
2018: €463k
2019: €620k
2020: €875k
2021: €958k
2022: €1.23M
2023: €1.39M
2024: €1.53M
2018 → 2025
Total assets
€2.14M▼ 4.5%
2024 · €2.24M
2018: €2.10M
2019: €2.11M
2020: €2.14M
2021: €2.21M
2022: €2.24M
2023: €2.17M
2024: €2.24M
2018 → 2025
Net result
€141k▲ 3.0%
2024 · €137k
2018: €144k
2019: €157k
2020: €255k
2021: €321k
2022: €269k
2023: €166k
2024: €137k
2018 → 2025
Working capital
€-379k▲ 16.7%
2024 · €-455k
2018: €-372k
2019: €-344k
2020: €-334k
2021: €-359k
2022: €-198k
2023: €-462k
2024: €-455k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€958k-€1.23M▲ 28.1%€1.39M▲ 13.6%€1.53M▲ 9.9%€1.67M▲ 9.2%
Operating result€268k-€267k▼ 0.1%€274k▲ 2.7%€234k▼ 14.6%€227k▼ 2.9%
Net result€321k-€269k▼ 16.1%€166k▼ 38.1%€137k▼ 17.5%€141k▲ 3.0%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 3% below 2024 and is the lowest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.14M
Fixed assets
€2.07M▲ 0.1%
Current assets
€68k▼ 60.0%
Equity and liabilities €2.14M
Equity
€1.67M▲ 9.2%
Debt
€467k▼ 34.2%
The debt ratio falls from 31.7% to 21.8%: equity grows while debt is paid down.
Key figures and ratios
EBITDA
€231k▼
2024 · €237k
Cash flow
€145k▲
2024 · €140k
Solvency
78.2%▲
2024 · 68.3%
Current ratio
0.15▼
2024 · 0.27
Quick ratio
0.15▼
2024 · 0.27
Debt / equity
0.28▼
2024 · 0.46
ROE
8.5%▼
2024 · 9.0%
ROA
6.6%▲
2024 · 6.1%
Interest coverage
9.05▲
2024 · 6.31
Debt
€467k▼
2024 · €710k
Debt ≤ 1 year
€447k▼
2024 · €625k
Debt > 1 year
€0▼
2024 · €61k
Income taxes
€60k▲
2024 · €59k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€2.24M€2.14M▼
Fixed assets21/28€2.07M€2.07M▲
Tangible fixed assets22/27€10k€11k▲
Plant, machinery and equipment23€10k€11k▲
Financial fixed assets28€2.06M€2.06M=
Current assets29/58€170k€68k▼
Amounts receivable within one year40/41€660€660=
Other amounts receivable41€660€660=
Cash at bank and in hand54/58€170k€67k▼
Deferred charges and accrued income490/1€190€0▼
Equity and liabilities
Total equity and liabilities10/49€2.24M€2.14M▼
Equity10/15€1.53M€1.67M▲
Contributions10/11€19k€19k=
Reserves13€496k€637k▲
Distributable reserves133€496k€637k▲
Profit (loss) carried forward14€1.02M€1.02M=
Amounts payable17/49€710k€467k▼
Amounts payable after more than one year17€61k€0▼
Financial debts170/4€61k€0▼
Amounts payable within one year42/48€625k€447k▼
Current portion of amounts payable after more than one year42€161k€75k▼
Trade debts44€3k€4k▲
Suppliers440/4€3k€4k▲
Taxes, remuneration and social security45€23k€16k▼
Taxes450/3€23k€16k▼
Other amounts payable47/48€437k€352k▼
Accrued charges and deferred income492/3€24k€21k▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3k€4k▲
Other operating charges640/8€254€186▼
Gross operating margin9900€238k€231k▼
Operating profit (loss)9901€234k€227k▼
Financial charges65/66B€38k€26k▼
Recurring financial charges65€38k€26k▼
Profit (loss) for the period before taxes9903€197k€202k▲
Income taxes67/77€59k€60k▲
Profit (loss) for the period9904€137k€141k▲
Profit (loss) for the period to be appropriated9905€137k€141k▲
Appropriation of the result
Profit (loss) to be appropriated9906€1.15M€1.16M▲
Profit (loss) brought forward from the previous period14P€1.02M€1.02M=
Transfer to equity691/2€137k€141k▲
To other reserves6921€137k€141k▲
The notes to these accounts (13 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
13-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 13 days late
2025
20-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 20 days late
2024
31-12
Financial
Weakest financial yearnet €137k ▼17.5%
Net result drops to €137k, the lowest in the series; recovery starts the following year.
20-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 20 days late
2023
22-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 22 days late
2022
31-12
Financial
Equity above €1MEq €1.23M ▲28.1%
5 profitable years in a row build equity to €1.23M.
18-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Highest result since 2018net €321k ▲25.7%
Net result €321k, the highest in the series.
12-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 12 days late
2020
27-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial
Equity above €500kEq €620k ▲34%
2 profitable years in a row build equity to €620k.
22-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
08-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 8 days late
2017
01-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 1 day late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Schilde · 1 establishment unit since 2014
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Seringenlaan 112970 SchildeGround area
2,237 m²
Building footprint
250 m²
Volume, LiDAR
1,044 m³
Parcel 11039D0027/00A000, Flanders · tallest building 6.6 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
Medicinal
since 20142.233.328.394
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11039D0027/00A000 | Flanders | 2,237 m² | 1 · 250 m² | 6.6 m · 1 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
FLOOR SERVICES
BE 0888.180.104
Maasmechelen · Eq €1.67M
Bovan Invest & Beheer
BE 0860.634.082
Lokeren · Eq €1.67M
Nutrivision
BE 0792.957.875
Sint-Niklaas · Eq €1.67M
DJ CONSULTING
BE 0454.320.977
Schilde · Eq €1.67M
TRI DEE PROJECTS
BE 0548.790.465
Gent · Eq €1.67M
Of 82,241 companies in sector 70200 we hold annual accounts for 52,391. 22,119 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded20-03-2014
Fiscal year end31-12
Activities, NACEBEL
70200Business and other management consultancy
70220Business consulting
Sources
Crossroads Bank for EnterprisesNational Bank · 12 filingsAddress and cadastre registers
Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.